A sweeping new review in the journal Lancet Psychiatry reports that commonly used antidepressants taken before or during pregnancy are not meaningfully linked to higher odds of autism or attention‑deficit/hyperactivity disorder (ADHD) in children once parental mental health and family factors are taken into account. The results should be a relief for many expectant parents who have agonized over medication risks, although the authors stress that treatment still needs to be tailored, weighing the harms of untreated depression against the benefits of medication and therapy.
The study at a glance
The systematic review and meta‑analysis pulled together 37 observational studies that included more than half a million pregnancies in which antidepressants were used, alongside roughly 25 million pregnancies without such exposure, according to EurekAlert!. Researchers looked at different classes of antidepressants, when they were taken (before conception, during pregnancy, and by fathers during the pregnancy period), and typical dosages. They relied on adjusted comparison groups in an effort to separate any effects of the drugs themselves from the influence of parental mental‑health history and broader family background.
What the numbers actually show
Before those adjustments, the data looked worrisome. The authors found that maternal antidepressant use during pregnancy appeared to be linked with about a 35% higher risk of ADHD and a 69% higher risk of autism without intellectual disability. Once they adjusted for maternal psychiatric history, family factors, and other confounders, those apparent risk increases mostly weakened or disappeared, according to Reuters. Similar patterns showed up for fathers taking antidepressants during the pregnancy period and for mothers using them before pregnancy, which points more toward shared familial or genetic vulnerability than a direct drug effect on the fetus.
Small exceptions and lingering questions
There were a few notable wrinkles. When the team focused on older tricyclic antidepressants such as amitriptyline and nortriptyline, they saw associations with greater ADHD and autism risk in children of mothers who already had pre‑existing, often more severe mental‑health conditions. As summarized in The Guardian, that signal may reflect how sick the mothers were or their past treatment histories rather than a straightforward drug effect, and it remains an area that needs more scrutiny.
Clinical takeaway: don't stop abruptly
Both the study authors and outside clinicians caution against pulling the plug on antidepressants during pregnancy based solely on older, inconsistent studies. They also warn that suddenly stopping these medications can worsen depression and create additional risks for both mother and baby, according to Psychiatric Times. For people with milder symptoms, talking therapies may be the preferred starting point. Those with moderate to severe illness are urged to talk with their obstetric and mental‑health providers about whether to continue medication, adjust the dose, or combine drugs with therapy.
How experts are reading it
Experts quoted by the Science Media Centre praised the review for its scale and careful methods, while also noting that observational research cannot definitively prove cause and effect. They are calling for more work on the biological mechanisms that might be involved and on antidepressant types that still have relatively little data behind them. The findings are already filtering into local news coverage; outlets such as KVIA in El Paso have highlighted the key messages for people who are pregnant or planning to be.
The bottom line for most patients is that current evidence does not support a causal link between commonly used antidepressants taken around pregnancy and later diagnoses of autism or ADHD in children. Treatment choices, however, should remain individualized and made in close consultation with clinicians. If you are pregnant or hoping to conceive, the next step is a frank conversation with your care team about your mental‑health history and the latest research, so your plan protects both your well‑being and your child’s.
